Nektar shares rise on safety study of pain drug

by admin on June 19, 2013

Shares of Nektar Therapeutics advanced Wednesday after the company reported data from a clinical trial of NKTR-181, a pain drug that Nektar says may be less addictive than older medications. The company …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: